![]() ![]() Food and Drug Administration (FDA) approval of SpravatoTM. Robison led the Utah site for the pivotal ketamine study for treatment-resistant depression by Janssen, leading to the U.S. From its dedicated research center in Springville, Utah, CCR has developed a strong track record providing contract research (CRO) services, including hosting clinical trials. ![]() Through Novamind’s global network of clinics and retreats (operating exclusively in jurisdictions where certain psychedelics are legal), Cedar Psychiatry anticipates expanding its service offerings to provide patients with increased access to psychedelic medicine, along with screening, preparation, and integration services.Ĭedar Clinical Research (“CCR”) now leads Novamind’s clinical research activities. Robison supervises and trains ketamine-assisted psychotherapy practitioners at Cedar Psychiatry’s clinics across Utah, and to date has guided thousands of ketamine therapy journeys and hundreds of SpravatoTM treatment sessions. Robison established a ketamine infusion practice at Intermountain Medical Center, Utah’s largest hospital. He was one of the first clinicians to use ketamine off-label for the treatment of depression in Utah. Robison is a thought leader in ketamine-assisted psychotherapy and psychedelic-medicine. In addition, Cedar Psychiatry is a leading provider of ketamine therapy, having administered over 3,000 ketamine-assisted psychotherapy sessions and over 700 SpravatoTM (esketamine) treatments since its inception. Founded in 2016, Cedar Psychiatry operates four outpatient mental health clinics near Salt Lake City, Utah, providing a wide range of services including psychotherapy, diagnostic evaluations, pharmacogenetic testing, psychiatric medication management and transcranial magnetic stimulation (TMS). With the closing of the Cedar Acquisitions, Reid Robison, MD, MBA, co-founder of Cedar Psychiatry and Cedar Clinical Research, will join Novamind’s senior leadership team.Ĭedar Psychiatry is now the central hub of Novamind’s global network of clinics and retreats offering legal, medically supervised psychedelic experiences. Total consideration paid by Novamind for the Cedar Acquisitions was CAN$3.05 million, consisting of CAN$1 million cash and CAN$2.05 million in Novamind common shares. ![]() (“Novamind”), a mental health and wellness company specialized in psychedelic-assisted psychotherapy, is pleased to announce that it has closed the acquisitions of Cedar Psychiatry LLC (“Cedar Psychiatry”), a specialized provider of ketamine-assisted psychotherapy and Cedar Clinical Research LLC (“Cedar Clinical Research”), a dedicated research center focused on psychedelic medicines, both based near Salt Lake City, Utah (the “Cedar Acquisitions”). Copper Prices Could See "Astronomical Rise" as Supply Concerns Increase.10 Largest Producers of Gold by Country. ![]()
0 Comments
Leave a Reply. |